Literature DB >> 28395752

Efficacy of a new spot-on formulation of selamectin plus sarolaner for cats against adult Ctenocephalides felis, flea egg production and adult flea emergence.

Adriano F Vatta1, William R Everett2, Susan J Holzmer3, Judith A Cherni3, Vickie L King3, Douglas Rugg3, Thomas Geurden4.   

Abstract

A new spot-on formulation of selamectin plus sarolaner was evaluated against fleas for adulticidal efficacy, and for the effect on egg production and hatching when applied to flea-infested cats. Ten male and ten female adult domestic shorthair cats were randomly assigned to one of two treatment groups based on pre-treatment flea counts. Cats received topical treatment on Day 0 in a single spot to the dorsal scapular area with either a placebo formulation or with the combination formulation at the minimal dose of 6.0mg selamectin plus 1.0mg sarolaner per kg bodyweight. On Days -1, 5, 12, 19, 26 and 33, cats were infested with approximately 100 (±5) unfed Ctenocephalides felis fleas. At 24h after treatment or 48h after subsequent flea infestation, cats were housed for a 20-h period in a cage to allow collection of flea eggs. At the end of this period, flea eggs were collected from the cages and cats were combed to remove and count live fleas. Emerged viable larvae and emerged adult fleas were counted 3days and 35days, respectively, after egg collection. The new spot-on formulation of selamectin plus sarolaner provided 100% efficacy against adult fleas up to Day 36 following a single application. Fleas on placebo-treated cats produced large numbers of eggs throughout the study, with individual counts ranging from 110 to 1256 eggs. Following treatment, four flea eggs were collected from a single selamectin/sarolaner-treated cat on Day 29, but there were no eggs collected from any other selamectin/sarolaner-treated animal during the study. No larvae or adult fleas developed from these four eggs. From the eggs collected from the placebo-treated cats, the mean percentage of live larvae and adults that emerged ranged from 67.3% to 84.2% and from 50.7% to 81.8%, respectively. A single topical treatment with a new spot-on formulation of selamectin plus sarolaner at the minimum label dose thus controlled fleas on cats and was 100% effective in preventing flea reproduction for over one month after treatment.
Copyright © 2017 Zoetis Services LLC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cat; Ctenocephalides felis; Flea; Isoxazoline; Larvicide; Ovicide; Reproduction; Sarolaner; Selamectin; Topical

Mesh:

Substances:

Year:  2017        PMID: 28395752     DOI: 10.1016/j.vetpar.2017.02.026

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

1.  Virulence of Aerial Conidia of Beauveria bassiana Produced under LED Light to Ctenocephalides felis (Cat Flea).

Authors:  Sarayut Pittarate; Malee Thungrabeab; Supamit Mekchay; Patcharin Krutmuang
Journal:  J Pathog       Date:  2018-11-01

2.  Using Proteomic Approaches to Unravel the Response of Ctenocephalides felis felis to Blood Feeding and Infection With Bartonella henselae.

Authors:  Marcos Rogério André; Pradeep Neupane; Michael Lappin; Brian Herrin; Vicki Smith; Taufika Islam Williams; Leonard Collins; Hongxia Bai; Gabriel Lemes Jorge; Tiago Santana Balbuena; Julie Bradley; Ricardo G Maggi; Edward B Breitschwerdt
Journal:  Front Cell Infect Microbiol       Date:  2022-01-28       Impact factor: 5.293

Review 3.  The Biology and Ecology of Cat Fleas and Advancements in Their Pest Management: A Review.

Authors:  Michael K Rust
Journal:  Insects       Date:  2017-10-27       Impact factor: 2.769

4.  A reverse vaccinology approach to the identification and characterization of Ctenocephalides felis candidate protective antigens for the control of cat flea infestations.

Authors:  Marinela Contreras; Margarita Villar; Sara Artigas-Jerónimo; Lidiia Kornieieva; Sergіі Mуtrofanov; José de la Fuente
Journal:  Parasit Vectors       Date:  2018-01-18       Impact factor: 3.876

5.  Safety and efficacy of a new spot-on formulation of selamectin plus sarolaner in the treatment and control of naturally occurring flea infestations in cats presented as veterinary patients in Australia.

Authors:  Raj Packianathan; Melissa Pittorino; Andrew Hodge; Natalie Bruellke; Kelly Graham
Journal:  Parasit Vectors       Date:  2020-05-06       Impact factor: 3.876

6.  Efficacy of Oral Sarolaner for the Treatment of Feline Otodectic Mange.

Authors:  Diefrey Ribeiro Campos; Jéssica Karoline de Oliveira Chaves; Brena Gava Guimarães; So Yin Nak; Gabriela Pereira Salça de Almeida; Isabela Scalioni Gijsen; Juliana de Moraes Intrieri; Fabio Barbour Scott
Journal:  Pathogens       Date:  2021-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.